May 18, 05
|
| NEW STORY |
| 11:00 ET |
Results Show Promise for Zelnorm in the Treatment of Upper Gastrointestinal Disorders
|
|
| NEW STORY |
| 10:42 ET |
Multiple Studies at DDW Report on Adacolumn(R) Apheresis Device in Treating Inflammatory Bowel Disease
|
|
| NEW STORY |
| 09:04 ET |
Synta Pharmaceuticals Presents Phase 2a Data at DDW for STA-5326 in Patients with Crohn's Disease
|
|
May 17, 05
|
| NEW STORY |
| 12:45 ET |
Vertex Pharmaceuticals Reports that Oral Hepatitis C Protease Inhibitor, VX-950, Dramatically Reduces Viral Levels in Phase Ib Clinical Study
|
|
| NEW STORY |
| 12:00 ET |
Higher Dose of Mesalamine Is More Effective in Moderately Active Ulcerative Colitis
|
|
| NEW STORY |
| 08:55 ET |
Kosan Presents Preclinical Data on New Motilin Agonists for Treating Gastrointestinal Disorders at Digestive Disease Week
|
|
May 16, 05
|
| 16:05 ET |
Positive Two-Year Data for Telbivudine for the Treatment of Chronic Hepatitis B Presented at 2005 Digestive Disease Week (DDW) Meeting
|
|
| 09:40 ET |
Study Compares Stomach Acid Control of Three Proton Pump Inhibitors in Chronic NSAID Users
|
|
| 09:04 ET |
Pegasys(R) Findings Suggest New Approaches to Maximize Hepatitis C Therapy
|
|
| 06:00 ET |
InterMune Announces Presentation of Clinical Data From Studies of Daily Infergen With and Without Ribavirin for the Treatment of HCV
|
|
| 06:00 ET |
InterMune Announces Presentation of Data on Infergen Plus Actimmune for the Treatment of HCV PEG-Nonresponders
|
|
| 06:00 ET |
InterMune Announces Presentation of Specificity and Tolerability Data for Two Novel Protease Inhibitor Drug Candidates
|
|
May 10, 05
|
| 16:48 ET |
Given Imaging Announces 85 Capsule Endoscopy Studies to Be Presented at Digestive Disease Week 2005
|
|
| 07:06 ET |
Vertex Pharmaceuticals Reports that VX-950, an Investigational Oral Hepatitis C Protease Inhibitor, Displays Potent Antiviral Activity in Early Clinical Study
|
|
May 09, 05
|
| 06:00 ET |
InterMune Announces Hepatitis C Presentations at Digestive Disease Week
|
|
May 02, 05
|
| 16:04 ET |
Protein Design Labs Announces First Quarter 2005 Financial Results
|
|
Apr 28, 05
|
| 16:11 ET |
Idenix Announces Data Presentations at the 2005 Digestive Disease Week Meeting
|
|
Mar 23, 05
|
| 08:02 ET |
Protein Design Labs Reports on Nuvion(R) (Visilizumab) End of Phase I Meeting Held With the FDA
|
|